Raymond Diradoorian - Jan 20, 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/Aaron Perlitsh
Stock symbol
LFCR
Transactions as of
Jan 20, 2023
Transactions value $
$0
Form type
4
Date filed
1/24/2023, 03:26 PM
Previous filing
Jun 2, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award $19.4K +2.77K $7.00 2.77K Jan 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Options Exercise -$19.4K -2.77K -100% $7.00 0 Jan 20, 2023 Common Stock 2.77K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units were granted on January 20, 2022.
F3 The restricted stock units vested on January 20, 2023.